Literature DB >> 692595

Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group.

L S Levine, M Zachmann, M I New, A Prader, M S Pollack, G J O'Neill, S Y Yang, S E Oberfield, B Dupont.   

Abstract

To document further the proposed genetic linkage between congenital adrenal hyperplasia due to 21-hydroxylase deficiency and HLA, 34 unrelated families from New York and Zurich, with a total of 48 patients, 48 siblings and their parents, were studied. All patients were HLA genotypically different from the healthy sibs; when two or more children were affected in the same sibship they were always HLA-B identical. The gene for 21-hydroxylase deficiency was separated by genetic recombination from the HLA-A locus and from the locus for glyoxalase I-polymorphism. No HLA-A, HLA-B or HLA-C antigen was selectively increased among the 34 unrelated patients. Lod-score analysis for HLA-B:21-hydroxylase deficiency gave a peak for theta approximately 0.00 at 5.20 for females and 4.30 for males, giving a total peak lod score of 9.5 at theta approximately 0.00 when male and female lod scores were combined. Close genetic linkage between HLA-B and 21-hydroxylase deficiency was thus established.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 692595     DOI: 10.1056/NEJM197810262991702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  28 in total

Review 1.  Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment.

Authors:  D Merke; M Kabbani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  HLADR5 and C4BQO high frequency and antinuclear antibodies positivity in patients with 21 hydroxylase deficiency from Campania region.

Authors:  F Parlato; G Pisano; G Misiano; E Cosentini; C Cacciapuoti; M R Cavalcanti; M Brai; A Bellastella
Journal:  J Endocrinol Invest       Date:  1992-06       Impact factor: 4.256

3.  Mutation analysis of the CYP21A2 gene in the Iranian population.

Authors:  Bahareh Rabbani; Nejat Mahdieh; Mohammad Tahgi Haghi Ashtiani; Bagher Larijani; Mohammad Taghi Akbari; Maria New; Alan Parsa; Jan P Schouten; Ali Rabbani
Journal:  Genet Test Mol Biomarkers       Date:  2011-10-21

4.  Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  P W Speiser; J Dupont; D Zhu; J Serrat; M Buegeleisen; M T Tusie-Luna; M Lesser; M I New; P C White
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

Review 6.  The Gordon Wilson Lecture. Congenital adrenal hyperplasia.

Authors:  M I New
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

7.  Neonatal screening programme for congenital adrenal hyperplasia in a homogeneous Caucasian population.

Authors:  E Cacciari; A Balsamo; A Cassio; S Piazzi; F Bernardi; S Salardi; A Cicognani; P Pirazzoli; F Zappulla; M Capelli
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 8.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review of current knowledge.

Authors:  G E Bacon; R P Kelch
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

9.  Detection of late onset steroid 21-hydroxylase deficiency by capillary gas chromatographic profiling of urinary steroids in children and adolescents.

Authors:  J Homoki; J Solyom; W M Teller
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

10.  The use of association data to identify family members at high risk for marker-linked diseases.

Authors:  W J Conte; J I Rotter
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.